Related Experiment Video

Updated: May 20, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Committee opinion No. 533: lead screening during pregnancy and lactation

    Obstetrics and Gynecology
    |July 25, 2012
    PubMed

    Insights

    Prenatal lead exposure harms mothers and infants, even at low levels. Recent findings show adverse effects at previously unrecognized exposure thresholds.

    Area of Science:

    • Environmental Health
    • Toxicology
    • Maternal-Fetal Medicine

    Background:

    • Prenatal lead exposure is a significant public health concern.
    • Adverse effects are documented across various maternal blood lead levels.
    • Emerging research indicates harm at lower exposure levels than previously understood.

    Purpose of the Study:

    • To summarize the known adverse effects of prenatal lead exposure.
    • To highlight the evolving understanding of lead toxicity thresholds.
    • To contextualize public health guidelines for lead-exposed pregnant women.

    Main Methods:

    • Literature review of studies on prenatal lead exposure.
    • Analysis of epidemiological data on maternal and infant outcomes.
    • Examination of guidelines from health organizations.

    Main Results:

    • Prenatal lead exposure negatively impacts maternal health and infant development.
    • The range of concerning maternal blood lead levels has been revised downwards.
    • Guidelines for screening and management were established in 2010.

    Conclusions:

    • Continued vigilance and updated guidelines are crucial for mitigating lead's impact.
    • Reducing environmental lead exposure is vital for protecting maternal and child health.
    • Further research is needed to fully understand long-term effects at low exposure levels.

    More Related Videos

    Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

    Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

    Published on: June 28, 2024

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

    Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

    Published on: August 25, 2014

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...